Final results of a Phase I/II dose escalation trial in non–small-cell lung cancer using three-dimensional conformal radiotherapy

This publication has 31 references indexed in Scilit:

• Selective mediastinal node irradiation based on FDG-PET scan data in patients with non–small-cell lung cancer: A prospective clinical study
  International Journal of Radiation Oncology*Biology*Physics, 2005
• Induction and Concurrent Chemotherapy With High-Dose Thoracic Conformal Radiation Therapy in Unresectable Stage IIIA and IIIB Non–Small-Cell Lung Cancer: A Dose-Escalation Phase I Trial
  Journal of Clinical Oncology, 2004
• Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study
  Lung Cancer, 2004
• Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy
  Radiotherapy and Oncology, 2004
• Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer
  Lung Cancer, 2004
• New Guidelines to Evaluate the Response to Treatment in Solid Tumors
  JNCI Journal of the National Cancer Institute, 2000
• Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial
  Radiotherapy and Oncology, 1999
• Radiotherapy Alone for Medically Inoperable Stage I Non-Small–Cell Lung Cancer: The Duke Experience
  International Journal of Radiation Oncology*Biology*Physics, 1998
• Endpoints for multimodal clinical trials in Stage III non-small cell lung cancer (NSCLC): a consensus report
  Lung Cancer, 1994
• Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1992